Immune Design Corp.
Utility Patents
Last updated:
List of all Immune Design Corp. patents 7 in total
| Status | Patent |
|---|---|
Grant | Utility: Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof Filling date: 7 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids Filling date: 7 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Materials and methods for producing improved lentiviral vector particles Filling date: 7 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: GLA monotherapy for use in cancer treatment Filling date: 7 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Multigenome retroviral vector preparations and methods and systems for producing and using same Filling date: 7 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Materials and methods for producing improved lentiviral vector particles Filling date: 7 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Vaccines for HSV-2 Filling date: 7 Sep 2025 Issue date: 27 Aug 2019 |
Showing 1 to 7 of 7 patents.